Ryanair to take Lufthansa-Air Berlin deal to EU court

Conor Coyle Sharecast | 13 Oct, 2017 09:09 - Updated: 09:11 | | |

ep un avionair berlin
Un Avión De Air BerlinAIR BERLIN
  • 25.42
  • 0.51%0.13
  • Max: 25.64
  • Min: 25.32
  • Volume: 2,567,322
  • MM 200 : n/a
20:48 17/10/17
  • 16.50
  • -0.42%-0.07
  • Max: 16.72
  • Min: 16.35
  • Volume: 1,635,090
  • MM 200 : n/a
17:20 17/10/17
  • 12,995.06
  • -0.07%-8.64
  • Max: 13,034.42
  • Min: 12,967.35
  • Volume: 0
  • MM 200 : n/a
20:49 17/10/17
  • 9,669.21
  • -0.42%-40.30
  • Max: 9,717.89
  • Min: 9,575.51
  • Volume: 0
  • MM 200 : n/a
17:19 17/10/17
  • 16.30
  • -22.38%-4.70
  • Max: 16.30
  • Min: 16.30
  • Volume: 1,338
  • MM 200 : n/a
17:37 17/10/17

Irish budget airline Ryanair is planning to challenge Lufthansa’s deal to buy part of another German carrier, Air Berlin.

Ryanair lodged a complaint with the European authorities over the €210m deal, which Lufthansa has sought in order to expand its Eurowings business.

Air Berlin has been searching for a buyer for several months after it filed for bankruptcy as a result of the withdrawal of its largest shareholder, Etihad Airlines.

Now Ryanair will challenge the deal on the basis that customers will see rising prices as a result of Lufthansa’s domination of airports across Germany.

"We will be referring the matter to the EU competition authority in due course," a spokesperson for Ryanair said.

Michael O’Leary’s firm has faced major problems in recent weeks as it seeks to deal with the fallout of thousands of cancelled flights due to an error with the scheduling of pilots' holidays.

More news

17 Oct US close: Markets finish higher amid busy earnings season

US markets finished in the green on Tuesday, with the Dow closing just short of the 23,000 mark which it breached for the first time ever earlier in the session, amid a busy third quarter earnings season on Wall Street.

17 Oct Europe close: Stocks slip ahead of US Fed Beige Book

Stocks on the Continent finished slightly lower as investors bid their time ahead of the release of the US central bank's Beige Book on Wednesday, against the backdrop of fresh intra-day records on Wall Street's main benchmarks with the Dow Industrials having climbed above the 23,000 point mark for the first time ever.

17 Oct Buy Spain as political risk is 'overstated' - Credit Suisse

Spanish equities look unusually cheap, said Credit Suisse on Tuesday, as political risk is "overstated" and the country is on track for at least 3% growth, with employment, housing and construction all on a growth tear.

17 Oct London close: Stocks move lower even as Sterling slips

London stocks closed lower on Tuesday even as the pound fell back against the dollar, albeit following a brief pop higher after data showed inflation surged to a five-year high last month, amid somewhat dovish remarks from Bank of England policymakers.

17 Oct Director dealings: Beazley executive director sells after profit warning

Adrian Cox, executive director of risk insurance and reinsurance group Beazley, sold 180,009 shares in the company on Tuesday at the price of 500p per share.

17 Oct Credit Suisse cuts Tate and Lyle's target price, reiterates 'neutral' rating

Ahead of Tate & Lyle's interim results on 2 November, Credit Suisse updated its forecasts and cut its target price to 710p while reiterating its 'neutral' rating.

17 Oct US open: Dow Industrials clambers atop 23,000 mark for first time

The Dow Industrials climbed past the 23,000 points mark for the first time ever, as the third-quarter earnings season got into full swing, and then slipped lower.

17 Oct Higher inflation means benefits pain for households, says IFS

State benefits for roughly 10m UK families will be reduced by £450 a year in real terms after inflation reached its highest level in five years on Tuesday, the Institute for Fiscal Studies calculated.

17 Oct FTSE 250 movers: Virgin Money gains on update, Workspace boosted by JPM note

London's FTSE 250 was down 0.4% to 20,140.65 in afternoon trade on Tuesday.

17 Oct Johnson and Johnson raises full year targets after strong third quarter

Healthcare giant Johnson and Johnson posted higher than expected profits for the three months to 30 September thanks to increased demand for its new cancer drugs and the additional revenue afforded to the group from its June acquisition of Swiss biotech company Actelion.